Thomas O. Daniel

Insider Reports History

Location
Summit, NJ
Signature
/s/ Jeff Boerneke, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas O. Daniel:

Company Role Class Num Shares Value Price $ Report Date Ownership
Gossamer Bio, Inc. Director Stock Option (Right to Buy) 115,000 25 Jun 2025 Direct
Magenta Therapeutics, Inc. Director Stock Option (Right to Buy) 20,000 28 Jun 2022 Direct
Larimar Therapeutics, Inc. Director Stock Option (right to buy) 8,300 12 May 2021 Direct

Insider Reports Filed by Thomas O. Daniel

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GOSS Gossamer Bio, Inc. 25 Jun 2025 1 $0 4 Director 26 Jun 2025, 16:40
GOSS Gossamer Bio, Inc. 06 Jun 2024 1 $0 4 Director 06 Jun 2024, 21:57
GOSS Gossamer Bio, Inc. 08 Jun 2023 1 $0 4 Director 09 Jun 2023, 16:13
DNTH Magenta Therapeutics, Inc. 28 Jun 2022 1 $0 4 Director 30 Jun 2022, 18:37
GOSS Gossamer Bio, Inc. 09 Jun 2022 1 $0 4 Director 15 Jul 2022, 17:15
GOSS Gossamer Bio, Inc. 09 Jun 2021 1 $0 4 Director 10 Jun 2021, 19:54
DNTH Magenta Therapeutics, Inc. 01 Jun 2021 1 $0 4 Director 03 Jun 2021, 18:30
LRMR Larimar Therapeutics, Inc. 12 May 2021 1 $0 4 Director 17 May 2021, 17:08